Phase 1 biotech developing antibody therapies for neurodegenerative diseases.
Industry: Health Care
Latest Trade: $3.00 0.00 (0.0%)
First Day Return: -9.6%
Return from IPO: -78.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/19/2021 |
Offer Price | $14.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $98 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/06/2022 |
Offer Price | $14.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $98 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2020 |
Employees at IPO | 30 |
Website www.vigilneuro.com |